ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KAPA Kairos Pharma Ltd

1.374
-0.076 (-5.24%)
15 Feb 2025 - Closed
Delayed by 15 minutes

Kairos Pharma Financial Summary

The current KAPA market cap is 17.65M. The company's latest EPS is USD -0.1410 and P/E is -10.07.

Quarter End
USD (US$)USD (US$)USD (US$)
Total Revenue
Operating Income
Net Income
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -1.94M-571k-1.71M
Net Income -2.15M-1.05M-1.81M
Quarter End
USD (US$)USD (US$)USD (US$)
Total Assets
Total Liabilities
Total Equity
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Assets 775k1.04M965k
Total Liabilities 1.94M2.22M3.04M
Total Equity -1.17M-1.18M-2.08M
Quarter End
USD (US$)USD (US$)USD (US$)
Operating
Investing
Financing
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Operating -412k-353k81k
Investing -109k N/A N/A
Financing 580k717k-425k
Market Cap 17.65M
Price to Earnings Ratio -10.07
Price to Sales Ratio 0
Price to Cash Ratio 197.22
Price to Book Ratio -8.78
Dividend Yield -

Share Statistics

Shares Outstanding 12.85M
Average Volume (1 week) 161.56k
Average Volume (1 Month) 1.07M
52 Week Change -65.65%
52 Week High 4.00
52 Week Low 0.851
Spread (Intraday) 0.08 (5.52%)

Company Info

Company Name Kairos Pharma Ltd
Address 108 w. 13th street suite 100
wilmington, delaware 19801
Website https://kairospharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock